Certified by Founder Lodge
ImmunoScape
Singapore - Singapore
START UP
1 Disclosed Funding Rounds $14,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company's proprietary Deep Imm
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 26 ,2022 | Unknown | $14,000,000 |
Anzu Partners
Amgen
EDBI Pte Ltd
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
